Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
4,646 total articles
Director Charles Thomas McMillen sold 30,000 shares of Castellum, Inc. (OTC:CTM) on March 25, 2026, for $21,129, according to a Form 4 filing. The transaction follows a recent share-price decline and leaves McMillen with 231,015 shares. Separately, the company has retired $400,000 of debt, increased cash to over $14 million, and its subsidiary Spec…
Corcept Therapeutics Chief Executive Officer Joseph K. Belanoff sold 26,198 shares on March 25, 2026, generating about $1.3 million in proceeds under a Rule 10b5-1 plan. The company recently secured FDA approval for Lifyorli and received an analyst upgrade, even as its stock has fallen and a securities class action was filed.
Arteris, Inc. President and CEO K. Charles Janac executed two stock sales on March 25 and March 26, 2026, disposing of a combined 40,000 shares for about $731,623. The transactions followed a period of notable share-price appreciation. The company also reported fourth-quarter 2025 results that exceeded consensus estimates for both revenue and earni…
A Tecogen director purchased 10,000 shares on March 27, 2026, increasing her holdings to 260,416 shares. The trade occurred as the stock was trading near $2.57 and follows a quarter in which Tecogen missed earnings and revenue estimates. Market research notes suggest the stock may be undervalued and the company carries more cash than debt.
Legend Biotech Chief Executive Officer Huang Ying sold 9,936 ordinary shares on March 25, 2026, for roughly $87,138, according to an SEC Form 4. The sale occurred as the stock traded near a 52-week low, even after the company reported a revenue beat for the fourth quarter and full-year 2025 driven by Carvykti. Analysts issued a range of price targe…
Eduard Grabscheid, chief financial officer of JFrog Ltd (NASDAQ: FROG), sold 9,043 ordinary shares on March 25, 2026, at $45.00 per share for proceeds of $406,935. The sale was made under a Rule 10b5-1 plan put in place May 16, 2025. After the transaction Grabscheid directly holds 224,796 shares. Separately, JFrog announced a new Agent Skills Regis…
RingCentral President and COO Kira Makagon disposed of 51,510 shares of Class A common stock across several transactions on March 26 and 27, 2026, generating roughly $1.8 million in proceeds. The trades were carried out under a Rule 10b5-1 plan adopted in March 2025. RingCentral reported modest fourth-quarter revenue growth, beat EPS expectations, …
JFrog Ltd director Sela Yossi sold 25,000 ordinary shares on March 25, 2026, realizing $1.13 million through multiple transactions executed between $45.00 and $45.32 per share. After the sale Yossi holds 103,922 shares. The transaction was carried out under a Rule 10b5-1 trading plan adopted on September 5, 2025. JFrog is trading near $43.34 with a…
JFrog Ltd Chief Executive Shlomi Ben Haim sold 25,000 ordinary shares on March 25, 2026, for roughly $1.13 million under a Rule 10b5-1 plan. The transaction leaves Ben Haim with 4,765,249 direct shares. The $5.22 billion software company shows robust gross margins and a net cash position but is flagged by InvestingPro as trading above Fair Value. R…
Mentor Capital, Inc. (OTC: MNTR) Chief Executive Officer Billingsley Chester purchased 4,100 shares of the company’s common stock across two transactions on March 25 and March 26, 2026, spending a combined $298. The purchases were disclosed in a Form 4 with the Securities and Exchange Commission and leave Chester with 3,200,396 directly held shares…
Paul Hukkanen, Scholastic CORP's senior vice president and chief accounting officer, sold 10,000 shares on March 25, 2026, for $394,000 after exercising options. The transaction coincides with a stock price near its 52-week high and follows Scholastic's fiscal third-quarter results and a proposed modified Dutch auction to repurchase up to $200 mill…
iBio Chief Legal Officer Marc Banjak acquired 13,934 shares of common stock on March 26, 2026, spending $23,055 across two transactions. The purchases come amid recent stock volatility, upbeat preclinical results for the company’s obesity candidate IBIO-610, analyst Buy ratings and a strong reported current ratio despite a modest market capitalizat…
Glen Ives, President and Chief Executive Officer of Castellum, Inc. (CTM), purchased 2,000 shares on March 27, 2026, at $0.6157 per share for a total of $1,231. The transaction leaves Ives with 199,616 shares. The purchase occurs as the stock trades near its 52-week low and follows several positive corporate developments: Castellum has retired its …
Sterling Infrastructure CEO Joseph A. Cutillo sold 50,000 shares on March 25, 2026, generating roughly $22.67 million under a pre-arranged Rule 10b5-1 plan. The transaction occurred while the stock traded below the sale range, after a 12-month rally of 256%. Separately, Sterling Construction reported robust fourth-quarter 2025 financials that excee…
Castellum, Inc. Chief Operating Officer Andrew Merriman purchased 2,000 shares of the company on March 27, 2026, for $0.6426 per share, a transaction valued at $1,285. The trade leaves Merriman with 536,000 shares directly held. The purchase coincides with the stock trading near its 52-week low and recent weekly weakness. Separately, Castellum has …
CSB Bancorp, Inc. (OTC: CSBB) director Cheryl M. Kirkbride purchased 9.464 shares on March 24, 2026, paying $62.00 per share for a total outlay of $586. The transaction occurred as the stock trades close to its 52-week peak of $64.69. The company’s valuation metrics include a price-to-earnings ratio of 12.23, a dividend yield of 2.77%, and a market…
Donaldson Co President Guillermo Briseno sold 20,600 shares on March 26, 2026, for roughly $1.75 million and exercised options to acquire the same number of shares. The transactions leave him with 29,267 directly held shares as the company reports a fiscal Q2 2026 earnings miss and a reiterated Equalweight rating from Morgan Stanley.
Director Earl Lewis purchased 5,000 shares of Tecogen Inc. (NASDAQ:TGEN) on March 27, 2026, paying $2.5192 per share for a total of $12,596. The transaction, executed through a trust, increases his direct holdings to 1,011,006 shares. The purchase comes after a 17% one-week rally in TGEN stock and amid research from InvestingPro that still ranks th…
A director of Farmers National Banc Corp purchased a sizable block of shares on March 26, 2026, while the company finalizes strategic growth moves including a merger with Middlefield Banc Corp that increases its asset base and branch footprint. The stock is trading below fair value per InvestingPro metrics and the bank continues a long track record…
UMH Properties director Matthew I. Hirsch acquired 500 shares of the company at $14.48 per share, a transaction valued at $7,240, according to a Form 4 filed with the SEC on March 27, 2026. The purchase raises his direct holdings to 60,792.30 shares and comes as the stock trades close to its 52-week low. The company reported a fourth-quarter 2025 e…
Michael Feld, Executive Vice President and Chief Revenue Officer of Becton Dickinson & Co, sold a small parcel of company stock on March 26, 2026, in a transaction executed under a pre-established Rule 10b5-1 trading plan. The company recently reported fiscal first-quarter 2026 results that outperformed consensus expectations on an ex-foreign-e…
A reported 10% owner of First Interstate Bancsystem Inc sold 3,000 shares of common stock on March 26, 2026, in a transaction disclosed on a Form 4 filing with the Securities and Exchange Commission. The trade generated $100,350 at a weighted average price of $33.45, with executed prices spanning $33.31 to $33.55. After the sale, reporting owners t…
Kopin Corporation CEO Michael Andrew Murray sold 33,334 shares on March 25, 2026, receiving roughly $77,234 under a Rule 10b5-1 trading arrangement. The transaction leaves Murray with 3,124,455 shares directly owned. The sale comes as Kopin reported a fourth-quarter 2025 revenue shortfall and as some analysts view the stock as overvalued relative t…
Murray Stahl, president and co-portfolio manager of RENN Fund, acquired 1,134 shares of RENN Fund, Inc. (RCG) on March 26, 2026, at $3.29 per share, increasing his direct holdings to 158,174 shares. The transaction totaled $3,730 and occurs while RCG shares have risen 28% over the prior six months and sit near their 52-week high, according to Inves…
Director Lewis Earl purchased 5,000 shares of Tecogen Inc. (NASDAQ:TGEN) common stock on March 26, 2026, paying $2.8817 per share for a total of $14,408. The trade occurred after the stock had risen 17% in the prior week, although shares were trading at $2.57 at the time of reporting. InvestingPro rates the stock as undervalued with a Fair Value of…
